Worth reading
38Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
0
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
11th Stock Acquisition Rights issued through a third-party allotment (with provisions for adjustment of the exercise price and suspension of exercise)
Intended allottee
EVO FUND (the allottee of the issued Stock Acquisition Rights)
Terms of the stock acquisition rights
Exercise price
¥195 (exercise price during the subject month). Details of the adjustment provisions and the adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total issued: 104,596 rights; unexercised balance as of the end of the preceding month: 92,000 rights; unexercised balance as of the end of the subject month: 92,000 rights
Most recent equity financing
Timing 12 February 2026 / Type 11th Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment and exercise suspension provisions) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | 11th Stock Acquisition Rights issued through a third-party allotment (with provisions for adjustment of the exercise price and suspension of exercise) |
| Intended allottee | EVO FUND (the allottee of the issued Stock Acquisition Rights) |
| Total number of issued shares | 16,101,892 shares (as of the end of the month preceding the subject month) → Not disclosed |
| Exercise price | ¥195 (exercise price during the subject month). Details of the adjustment provisions and the adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 104,596 rights; unexercised balance as of the end of the preceding month: 92,000 rights; unexercised balance as of the end of the subject month: 92,000 rights |
| Most recent equity financing | Timing 12 February 2026 / Type 11th Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment and exercise suspension provisions) / Amount Not disclosed |
Items this document does not state (22)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company has not stated a reason.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.